We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$172M
1-Year Est. Return
21.18%
This Fund
S&P 500
This Quarter
Est. Return
+21.65%
1 Year Est. Return
+21.18%
3 Year Est. Return
+55.24%
5 Year Est. Return
+52.07%
10 Year Est. Return
+229.25%
AUM
$162M
AUM Growth
+$18M
(+12%)
Cap. Flow
-$242K
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
44.84%
Holding
76
New
9
Increased
16
Reduced
21
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$6.41M |
| 2 |
Hershey
HSY
|
+$5.83M |
| 3 |
T. Rowe Price
TROW
|
+$5.28M |
| 4 |
Peloton Interactive
PTON
|
+$4.71M |
| 5 |
Salesforce
CRM
|
+$4.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$5.26M |
| 2 |
Qiagen
QGEN
|
+$4.61M |
| 3 |
Palo Alto Networks
PANW
|
+$4.12M |
| 4 |
BDN
Brandywine Realty Trust
BDN
|
+$3.94M |
| 5 |
General Mills
GIS
|
+$3.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.89% |
| 2 | Technology | 18.61% |
| 3 | Consumer Staples | 17.54% |
| 4 | Communication Services | 16.02% |
| 5 | Financials | 8.24% |
Similar funds
CRFG
TA
BIA
GWCM
PWM
SPF
AIG
NWMG
Prentiss Smith & Co's Q2 2020 Portfolio in Review
As of Q2 2020, Prentiss Smith & Co held 76 positions worth $162M, up 12% from $144M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Prentiss Smith & Co's Q2 2020 filing shows 9 new, 16 increased, 21 reduced and 11 closed positions. Its largest new stake was Hershey: 43,394 shares worth $5.63M. The largest sale was Gilead Sciences, an estimated $5.26M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Staples.
- Prentiss Smith & Co's largest Q2 2020 buy was Hershey: 43,394 shares worth $5.63M.
- Prentiss Smith & Co added most to Colgate-Palmolive in Q2 2020, an estimated $6.41M increase.
- Prentiss Smith & Co's biggest Q2 2020 reduction was Unilever, cutting an estimated $3.16M.
- Prentiss Smith & Co fully exited Gilead Sciences in Q2 2020, selling an estimated $5.26M.
- Prentiss Smith & Co's ten largest holdings make up 45% of its $162M portfolio in Q2 2020.
- Prentiss Smith & Co opened 9 new positions and closed 11 in Q2 2020.
- Prentiss Smith & Co's portfolio value rose 12% quarter-over-quarter to $162M.
Based on Prentiss Smith & Co's 13F filing for Q2 2020, filed 13 Jul 2020.